Defining Higher-Risk Chronic Myeloid Leukemia: Risk Scores, Genomic Landscape, and Prognostication

PURPOSE OF REVIEW: The chronic myeloid leukemia (CML) treatment success story is incomplete as some patients still fail therapy, leading to end-stage disease and death. Here we discuss recent research into CML incidence, the role of comorbidities on survival and detecting patients at risk of failing...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahrin, Nur Hezrin, Wadham, Carol, Branford, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Chronic Myeloid Leukemias (V Oehler, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712352/
https://www.ncbi.nlm.nih.gov/pubmed/35932396
http://dx.doi.org/10.1007/s11899-022-00668-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712352/
https://www.ncbi.nlm.nih.gov/pubmed/35932396
http://dx.doi.org/10.1007/s11899-022-00668-2

Ejemplares similares